Disease-related research focuses primarily on melanoma, drug-related research on anti-CTLA-4 monoclonal antibodies and anti-PD-1 monoclonal antibodies, and adverse events research on autoimmune hypophysitis and diabetes. The gene discussed is CTLA4; the disease is primary hypophysitis.